Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
International Journal of Hematology
|
March 11, 2020
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line
Masatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, et al.
Annals of Hematology
|
November 8, 2023
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT
Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, et al.
Blood Advances
|
January 4, 2020
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, et al.
International Journal of Hematology
|
November 28, 2023
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.
International Journal of Hematology
|
December 13, 2023
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.
Blood Advances
|
September 13, 2021
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Isamu Sugiura, Noriko Doki, Tomoko Hata, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
International Journal of Hematology
|
March 11, 2020
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line
Masatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, et al.
Annals of Hematology
|
November 8, 2023
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT
Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, et al.
Blood Advances
|
January 4, 2020
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, et al.
International Journal of Hematology
|
November 28, 2023
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.
International Journal of Hematology
|
December 13, 2023
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.
Blood Advances
|
September 13, 2021
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Isamu Sugiura, Noriko Doki, Tomoko Hata, et al.
Page
of 4